WCN26-4399 KIDNEY-ALONE TRANSPLANTATION WHILE ON siRNA THERAPY FOR PRIMARY HYPEROXALURIA TYPE 1: A MULTINATIONAL RETROSPECTIVE CASE SERIES FROM THE PH1NITx WORKING GROUP
Atessa Bahadori(Hospital for Sick Children), Hillarey Stone, Peggy Perrin(Hôpitaux Universitaires de Strasbourg), Justine Bacchetta(Université Claude Bernard Lyon 1), Chia Wei Teoh(University of Toronto), Armando J. Lorenzo(Hospital for Sick Children), William Hanf, Matthew C. Breeggemann, Daniel G. Fuster(University Hospital of Bern), Elizabeth Harvey(Hospital for Sick Children), Douglas R. Stewart(Cancer Genetics (United States)), Pietro Manuel Ferraro(Università Cattolica del Sacro Cuore), Carmen Ávila-Casado(Instituto Nacional de Cardiología), Alanoud Alshami, Chiara Caletti, Peter Schulga, Déborah Chaintreuil, Yannis Lombardi(Centre National de la Recherche Scientifique), Sander F. Garrelfs(Emma Kinderziekenhuis), Thomas Stehle, Nithiakishna Selvathesan(University of Toronto), Michael J.G. Somers(Boston Children's Hospital), Efrat Ben Shalom, A.-L. Sellier-Leclerc(Hôpital Femme Mère Enfant), Asma Nasir(University of Toronto), B. Hoppe(Oxalosis and Hyperoxaluria Foundation), Wesley Hayes, Bahbah Hebatallah, Marie Matignon, Nithikishna Selvathesan(Hospital for Sick Children), Mathieu Lemaire(Hospital for Sick Children), Istvan Mucsi(University of Toronto), Alexandre Karras, Dany Anglicheau, Michelle Baum, Franz Schaefer, Christopher T. Chan, Barbara Buscemi, Alexander Ritter, Andrea Ranghino, Alice Koenig, Mariella D'Alessandro, Vladimir Belostotsky(McMaster Children's Hospital), Ashlene M. McKay, Stéphanie Clave
Cited by 0
Related Papers
Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry
|American Journal of Kidney Diseases|2009|690
A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
|Journal of the American Society of Nephrology|2014|660
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy
|Kidney International|2005|510
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505